This inventor holds 1 USPTO granted patent. Top assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations in Cancer Therapy by Katarzyna Ann Rejniak
Introduction
Katarzyna Ann Rejniak is a prominent inventor based in Tampa, FL, who has made significant contributions to the field of personalized cancer therapy. Her innovative work focuses on the analysis and prediction of pathology cases, aiming to enhance the accuracy of cancer diagnoses and treatment strategies.
Latest Patents
Katarzyna holds a patent titled "Pathology case review, analysis and prediction." This invention encompasses systems and methods for personalized cancer therapy that utilize the analysis of pathology slides. The technology targets specific regions in a single sample, interrogating the feature data of a relatively large number of cells. The patent describes advanced pathology case review tools that include analysis, visualization, and prediction modeling. These tools provide novel information to pathologists, aiding in the diagnosis of diseases. Furthermore, the invention outlines a user interface designed to assist physicians in making informed diagnoses. Complex computer learning algorithms are employed to combine and mine data sets, recommending optimal treatment strategies. A computer interface allows pathologists to access this data instantly, facilitating more accurate diagnoses.
Career Highlights
Katarzyna is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where she continues to advance her research in cancer therapy. Her work is pivotal in bridging the gap between pathology and personalized medicine, contributing to improved patient outcomes.
Collaborations
Katarzyna collaborates with esteemed colleagues, including Mark Cassidy Cridlin Lloyd and Marilyn Yuanxin Ma Bui. These partnerships enhance the research and development of innovative solutions in cancer treatment.
Conclusion
Katarzyna Ann Rejniak's contributions to personalized cancer therapy through her innovative patent demonstrate her commitment to improving diagnostic accuracy and treatment strategies. Her work is a testament to the potential of technology in transforming healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
